New York, NY – (NISMAGAZINE) – 04/02/2013- BGC Partners, Inc. (NASDAQ:BGCP) is up by whopping 48.57% and to close at $5.72. BGCP announced that it has agreed to sell its electronic Treasury trading platform to Nasdaq OMX Group for $1.23 billion, added to it is an earn-out of about $484 million of NDAQ’s common stock (15 million) to be paid over 15 years. For eSpeed NDAQ will pay $750 million in cash. This transaction will help boost the EPS of BGCP. We can see huge volume in the stock. Around 20.53 million shares have exchanged hands in today’s trading session, as compared to its average volume of 1.60 million. The market capitalization of the stock is $897.67 million. The stock has an RSI of 73.42 indicating that the stock has moved into an oversold region and it to close at above its 50 days moving average of $4.15.
How Should Investors Trade BGCP Now? Find out here.
Inovio Pharmaceuticals Inc (NYSEAMEX:INO) down by 8% to close at $0.52. The stock has had a volatile trading session since past one year, the stock managed to move up from the beginning of March. The stock is now trading below its 50 days moving average of $0.648. The RSI of the stock is now 36.01 and if the stock continues to move downward it will move into an oversold zone, where from we can expect the stock to recover. INO announced preliminary results of Phase-II clinical study of ChronVac-C® vaccine which is used to treat hepatitis C virus, the by its collaborator ChronTech AS, of their open label phase II clinical study.
How Should Investors Trade INO Now? Find out here.
Groupon Inc (NASDAQ:GRPN) is down by 5.62% and to close at close to $5.70. The stock is close to its 50 days moving average of $5.47 and has an RSI of 50.43. Around 16.07 million shares have exchanged hands in today’s trading session. The market capitalization of the stock is $3.70 billion. The 52-week range of the stock is $2.60 and $16.57. GRPN announced that it has achieved an award for the category of Best POS Transformation at the 2013 PYMNTS.com Innovator Awards. UBS’s Analyst Eric Sheridan gave a sell rating to the stock and posted that GRPN have an “unproven business model”, the target given by UBS is $4.40. GRPN is trying to find out how to absorb new services, besides its original business model. GRPN is seeking for a change in management who can bring back the soundness and expand the business.
Is GRPN a solid investment at these levels? Find out here.
Subscribe for FREE to receive our “50 Stock Trading Rules No Hedge Fund Wants You To Know!” E-Book: http://hiddengemstocks.com/trade.html
HiddenGemStocks.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HiddenGemStocks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HiddenGemStocks.com website, for complete risks and disclosures.